1)Benzofuran Derivatives as Potent, Orally Active S1P1 Receptor Agonists: A Preclinical Lead Molecule for MS
Ashis K. Saha et al.
ACS Med. Chem. Lett., Article ASAP
- DOI:
http://dx.doi.org/10.1021/ml100227q
Ulrike E. Hille, Christina Zimmer, Carsten A. Vock, and Rolf W. Hartmann
ACS Med. Chem. Lett., Article ASAP
- DOI:
http://dx.doi.org/10.1021/ml100071j
Matthew T. Burger et al.
ACS Med. Chem. Lett., Article ASAP
- DOI:
http://dx.doi.org/10.1021/ml1001932
Gregory R. Ott et al.
ACS Med. Chem. Lett., Article ASAP
- DOI:
http://dx.doi.org/10.1021/ml100158s
Eugene L. Piatnitski Chekler
ACS Med. Chem. Lett., Article ASAP
- DOI:
http://dx.doi.org/10.1021/ml1001568